Academy Research Fellow

Research line: Nano

Role in project: Aptamer-based targeting technologies, RNA therapy


My group focuses on the selection of aptamers that enable the safe and precise delivery of drugs to ocular tissues. We also have expertise in the delivery of RNA-based therapeutics to retinal cells by using different nanoparticles. In the Flagship, my team is developing novel targeted, controlled delivery systems for the treatment of blinding eye disorders. Research interests: eye diseases, ocular barriers, drug targeting, drug delivery, RNA therapy